Monitoring community pharmacist's quality of care: A feasibility study of using pharmacy claims data to assess performance

BMC Health Services Research

Volumn 11, Issue , 2011, Pages

  Winslade, Nancy ^a   Taylor, Laurel ^b   Shi, Sherry ^a   Schuwirth, Lambert ^c   Van Der Vleuten, Cees ^c   Tamblyn, Robyn ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Canadian Patient Safety Institute   (Canada)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; CANADA; DRUG CONTRAINDICATION; DRUG USE; FACTUAL DATABASE; FEASIBILITY STUDY; FEMALE; HEALTH CARE QUALITY; HEALTH INSURANCE; HUMAN; INSURANCE; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PHARMACY; RESPIRATORY TRACT DISEASE; STANDARD; STATISTICS;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ASTHMATIC AGENTS; ANTIHYPERTENSIVE AGENTS; BENZODIAZEPINES; COMMUNITY PHARMACY SERVICES; DATABASES, FACTUAL; DRUG UTILIZATION REVIEW; FEASIBILITY STUDIES; FEMALE; HUMANS; INSURANCE CLAIM REPORTING; INSURANCE, PHARMACEUTICAL SERVICES; MALE; MIDDLE AGED; PATIENT COMPLIANCE; QUALITY OF HEALTH CARE; QUEBEC; RESPIRATORY TRACT DISEASES;

EID: 78651445650     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-11-12     Document Type: Article

References (33)

1. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. LAAG Thomsen B Winterstein LS Søndergaard A Haugbølle Melander, Annals of Pharmacotherapy 2007 41 9 1411 26 10.1345/aph.1H658 17666582
2. Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. RL Howard AJ Avery PD Howard M Partridge, Qual Safety Health Care 2003 12 4 280 5 10.1136/qhc.12.4.280
3. Medication use in an imperfect world: drug misadventuring as an issue of public policy, Part 1. HR Manasse Jr, Am J Hosp Pharm 1989 46 5 929 44 2729301
4. Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study. PJ Zed RB Abu-Laban RM Balen PS Loewen CM Hohl JR Brubacher K Wilbur MO Wiens LJ Samoy K Lacaria RA Purssell, CMAJ 2008 178 12 1563 9 18519904
5. Hospital admissions associated with adverse drug reactions: a systematic review of prospective observational studies. C Kongkaew PR Noyce DM Ashcroft, Ann Pharmacotherapy 2008 42 7 1017 25 10.1345/aph.1L037
6. Adverse drug events and medication errors in Australia. WB Runciman EE Roughead SJ Semple RJ Adams, Inter J Qual Health Care 2003 15 Supp1 49 59 10.1093/intqhc/mzg085
7. Opportunities and Responsibilities in Pharmaceutical Care. CD Hepler LM Strand, Am J Pharm Ed 1989 53 7S 5S
8. American Pharmaceutical Association, An APhA White Paper on the Role of the Pharmacist in Comprehensive Medication Use Management: The Delivery of Pharmaceutical Care Washington, DC: American Pharmaceutical Association 1992
9. ASHP statement on pharmaceutical care. American Society of Hospital Pharmacists, Am J Hosp Pharm 1993 50 1720 3
10. Tenth Pharmacy Trends Report, Canada's report for pharmacists on professional and business trends 2003 http://216.150.136.82/chronic-lobby- category.asp?siteID=273&catId=1637&sub1=2 Accessed August 12, 2010
11. Association of Faculties of Pharmacy of Canada, Educational Outcomes for First Professional Degree Programs in Pharmacy 2010 http://afpc.info/downloads/ 1/AFPC-Education-Outcomes-AGM-June-2010.pdf accessed on August 11, 2010
12. National Association of Pharmacy Regulatory Authorities, Model Standards of Practice for Canadian Pharmacists 2009 http://129.128.180.43/Content-Files/ Files/Model-Standards-of-Prac-for-Cdn-Pharm-March09.pdf accessed March 24, 2010
13. Revalidation of doctors in Canada. WD Dauphinee, BMJ 1999 319 1188 90 10541516
14. Integrating Performance Assessment, Maintenance of Competence, and Continuing Professional Development of Community Pharmacists. N Winslade R Tamblyn L Taylor L Schuwirth C Van der Vleuten, Am J Pharm Ed 2007 71 1 Article 15
15. Assessment of the Practicing Physician: challenges and opportunities. ES Holmboe, J Cont Ed Health Prof 2009 28 Suppl 1 4 10
16. Shared Medical Regulation in a Time of Increasing Calls for Accountability and Transparency. K Shaw CK Cassel C Black W Levinson, JAMA 2009 302 18 2008 14 10.1001/jama.2009.1620 19903922
17. Assessing the performance of doctors in teams and systems. ED Farmer JD Beard WD Dauphinee T LaDuca KV Mann, Medical Education 2002 36 942 948 10.1046/j.1365-2923.2002.01311.x 12390462
18. Clinical pharmaceutical services in retail practice II. Factors influencing the provision of services. AR Neslon Jr RN Zelnio CE Beno, Drug Intell Clin Pharm 1984 18 12 992 6 6510226
19. Achieving re-professionalization: factors that influence the adoption of an 'extended role' by community pharmacists. A national survey. A Ruston, J Soc Admin Pharm 2001 18 103 10
20. Pharmacy Quality Alliance, PQA-Endorsed Starter Set of Measures 2006 http://www.pqaalliance.org/files/PQAMeasureDescriptionsForDemonstrations.pdf accessed August 13, 2010
21. Pharmacy Quality Alliance, Highlights from the Five Phase I Demonstration Projects 2009 http://www.pqaalliance.org/files/ PQACombined5DemoProjectsTemplate.pdf Accessed August 12, 2010
22. Physician Clinical Performance Assessment: Prospects and Barriers. BE Landon SLT Normand D Blumenthal J Daley, JAMA 2003 290 1183 9 10.1001/jama.290.9.1183 12953001
23. Can the Quality of Care in Family Practice Be Measured Using Administrative Data? A Katz RA Soodeen B Bogdanovic C De Coster D Chteau, Health Services Research 2006 41 6 2238 54 10.1111/j.1475-6773.2006.00589.x 17116118
24. ABC of learning and teaching in medicine. Work based assessment. JJ Norcini, BMJ 2003 326 753 5 10.1136/bmj.326.7392.753 12676847
25. Canadian asthma consensus report, 1999. LP Boulet A Becker D Berube R Beveridge P Ernst, CMAJ 1999 161 11 Suppl 1 S62 10906907
26. The use of -agonists and the risk of death and near-death from asthma. WO Spitzer S Suissa P Ernst RI Horwitz B Habbick D Cockcroft JF Boivin M McNutt S Buist AS Rebuck, N Engl J Med 1992 326 501 506 10.1056/NEJM199202203260801 1346340
27. A cohort analysis of excess mortality in asthma and the use of inhaled beta agonists. S Suissa P Ernst JF Boivin RI Horwitz B Habbick D Cockcroft L Blais M McNutt AS Buist WO Spitzer, Am J Respir Crit Care Med 1994 149 604 10 8118625
28. Continuous professional development: The Ontario experience in professional self-regulation through quality assurance and peer review. Z Austin D Croteau A Marini C Violato, Am J Pharm Ed 2003 67 2 Article 56
29. Alberta College of Pharmacists, RxCEL Competence Program https://pharmacists.ab.ca/nContinuingCompetence/default.aspx [Accessed August 12, 2010].
30. Quebec Order of Pharmacists, Professional Inspection Program http://www.opq.org/fr/renseignements/directions/services [Accessed August 12, 2010]
31. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. R Tamblyn G Lavoie L Petrella J Monette, J Clin Epidemiol 1995 48 8 999 1009 10.1016/0895-4356(94)00234-H 7775999
32. Pay-for-Performance Programs n Family Practices in the United Kingdom. T Doran C Fullwood H Gravelle D Reeves E Kontopantelis U Hiroeh M Roland, NEJM 2006 355 375 84 10.1056/NEJMsa055505 16870916
33. Implementing cognitive services in community pharmacy: a review of facilitators used in practice change. AS Roberts S Benrimoj TF Chen KA Williams P Aslani, Inter J Pharm Pract 2006 14 3 163 170 10.1211/ijpp.14.3.0002 (Pubitemid 44368350)